Atom Investors LP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Atom Investors LP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$17,039
-19.8%
13,1070.0%0.00%
-50.0%
Q2 2023$21,233
-23.9%
13,1070.0%0.01%
-46.7%
Q1 2023$27,918
-59.3%
13,107
-29.2%
0.02%
-55.9%
Q4 2022$68,531
+226.3%
18,522
-35.7%
0.03%
+385.7%
Q3 2022$21,000
-12.5%
28,821
-5.3%
0.01%
-30.0%
Q2 2022$24,000
-14.3%
30,4220.0%0.01%
-23.1%
Q1 2022$28,00030,4220.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders